Conmed Healthcare Management, Inc. Reports Record Revenues for Third Quarter and Year-to-Date 2009
Third Quarter Revenue Increases 18.3% to $13.6 Million; Year-to-Date Revenue Increases 36.7% to a Record $38.8 Million
Hanover, Md.-- (BUSINESS WIRE)—November 12, 2009 -- Conmed Healthcare Management, Inc. (NYSE - Amex: CONM - News), a leading full service provider of correctional facility healthcare services to county detention centers, today announced financial results for the three and nine month periods ended September 30, 2009.
Third Quarter Financial Highlights
| · | Net revenue increased 18.3% to $13.6 million from $11.5 million in last year's comparable period. |
| · | Gross profit increased 32.3% to $2.7 million (20.0% gross margin), compared to $2.1 million (17.9% gross margin) in last year’s same period. |
| · | Operating income was approximately $331,000 compared to operating income of $72,000 in the year ago period. |
| · | Net income of approximately $854,000, or $0.07 per share, included $756,000 for a change in fair value of derivatives, compared to net income of approximately $108,000, or $0.01 per share, in the year-ago period. |
| · | The Company generated approximately $1.3 million in operating cash flow in the third quarter, and finished the quarter with $10.1 million in cash and cash equivalents, or $0.71 per diluted share, as of September 30, 2009. |
Third Quarter Results
Net revenue for the three months ended September 30, 2009 increased $2.1 million, or 18.3%, to $13.6 million from $11.5 million in last year's comparable period. The revenue improvement resulted from the addition of contracts signed with new jurisdictions since June 30, 2008: Caroline County, MD; Coos County, OR; Creek County, OK; Pima County, AZ; Washington County, MD; and Western Virginia Regional Jail, VA. Revenues also increased as a result of the acquisition of Correctional Mental Health Services, LLC (“CMHS”) on November 4, 2008 and expansion of services from existing contracts and price increases related to existing services.
"Our results again were solid across the board,” commented Richard Turner, Chairman and Chief Executive Officer of Conmed. “We achieved record revenues in the third quarter and first nine months of 2009, managed our cost structure extremely well, achieved 20% gross margins, and generated a significant amount of cash. During the quarter we were engaged in renewal discussions with several key accounts, putting the final touches on three new sites that we simultaneously opened early in the quarter, and working diligently to develop our new business pipeline and prudently manage our growth.”
Dr. Turner concluded, “We remain focused on both innovation and quality improvement programs to continue to differentiate ourselves in the marketplace as a go-to provider of outsourced high quality and standards compliant healthcare services for correctional facilities. Our quality of service, our attention to managing our client’s healthcare costs as well as our excellent record in compliance and customer retention remain key factors in attracting new and renewed business. The outstanding job we have done in servicing our accounts continues to result in maintaining a renewal and retention rate that is unmatched in our industry.”
Total healthcare expenses for the period ended September 30, 2009 were $10.9 million compared to $9.5 million in the year-ago period. The increase reflects increased healthcare and mental health staffing to support new business, which was partially offset by a decrease in spending for medical expenses reflecting lower hospitalization, outpatient and pharmacy expenditures. Gross profit increased 32.3% to $2.7 million, or 20.0% gross margin, compared to $2.1 million, or 17.9% gross margin, in the prior year period.
Total operating expenses were $2.4 million for the quarter ended September 30, 2009 compared to $2.0 million for the year-ago period. Operating expenses as a percentage of sales were 17.6% compared to 17.3% in the year-ago period. Selling, general and administrative expenses for the third quarter were $2.0 million or 14.8% of revenue compared to $1.5 million or 12.9% of revenue for the year-ago quarter and primarily reflects investments in additional management and administrative personnel required to support the new contracts and services added in 2009, as well as to sustain the Company during anticipated future growth plus increased travel, legal and accounting expenses.
Conmed reported operating income of approximately $331,000 in the third quarter compared to operating income of approximately $72,000 in the third quarter last year. Net income was approximately $854,000, or $0.07 per share, compared to net income of approximately $108,000, or $0.01 per share, in the year-ago period. The third quarter 2009 net income included a $756,000 change in the fair value of derivatives**.
For the third quarter of 2009, adjusted EBITDA*, a non-GAAP measure, grew to approximately $870,000 compared to approximately $736,000 in the prior year third quarter.
Year-to-Date Results
Net revenue for the nine months ended September 30, 2009 increased $10.4 million, or 36.7%, to a record $38.8 million from $28.4 million for last year's comparable period. Approximately $9.7 million, or 93.5%, of the year-over-year increase is due to the addition of new medical service contracts acquired after December 31, 2007. Total healthcare expenses for the nine months ended September 30, 2009 were $30.8 million compared to $23.3 million in the year-ago period. For the nine months, gross profit increased 59% to $8.0 million, representing 20.6% gross margin, compared to gross profit of $5.0 million or 17.7% gross margin in last year's same period.
Total operating expenses were $7.4 million, or 19.1% of revenue, for the nine months ended September 30, 2009 compared to $6.1 million, or 21.5% of revenue, for the year-ago period. Conmed's operating income was approximately $598,000 compared to an operating loss of $1.1 million in the same period last year. The net loss was approximately $1.4 million, or $0.11 loss per basic and fully diluted share (based on approximately 12.5 million weighted average shares outstanding) compared to a loss of $938,000, or $0.08 loss per basic and fully diluted share (based on approximately 12.0 million weighted average shares outstanding) in the year ago period. Included in the $1.4 million loss for the nine-month period, the company had a $1.7 million non-cash charge for the change in the fair value of derivatives. Without this charge the company would have had net income of approximately $0.2 million**.
For the first nine months of 2009, adjusted EBITDA* was approximately $2.7 million compared to approximately $881,000 in last year’s same period.
The Company generated approximately $1.3 million in operating cash flow in the quarter ended September 30, 2009, and had $10.1 million in cash and cash equivalents as of September 30, 2009 compared to $7.5 million at December 31, 2008
*Use of Non-GAAP Measures
In addition to containing results that are determined in accordance with accounting principles generally accepted in the United States of America (GAAP), this press release also contains the Company’s “EBITDA” results, which are non-GAAP earnings results that exclude certain items. Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) and adjusted EBITDA are key indicators used by management to evaluate operating performance. While EBITDA and adjusted EBITDA are not intended to replace any presentation included in the consolidated financial statements under GAAP and should not be considered an alternative to operating performance or an alternative to cash flow as a measure of liquidity, the Company believes this measure is useful to investors in assessing its capital expenditures and working capital requirements. This calculation may differ in method of calculation from similarly titled measures used by other companies. Adjusted EBITDA, as used in the press release, represents income from continuing operations before interest, taxes, depreciation and amortization adjusted for stock-based compensation, gains or losses on the sale of assets, impairment charges, change in fair value of derivative financial instruments and other unusual or non-recurring transactional events. A reconciliation of EBITDA and adjusted EBITDA to the nearest comparable GAAP financial measures is included in the financial schedules accompanying this press release. The adjusted financial measures, as well as other information in this press release, should be read in conjunction with the Company’s financial statements filed with the Securities and Exchange Commission.
**Fair Value Measurements -- Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity’s Own Stock:
We are required to record a non-cash charge to our GAAP results due to our adoption of derivative accounting rules for equity-linked financial instruments. Equity-linked financial instruments consist of stock warrants issued by the Company that contain a strike price adjustment feature. In accordance with derivative accounting for warrants, we calculated the fair value of warrants using the Black-Scholes option pricing model and the assumptions used are described in our Quarterly Report on Form 10-Q for the periods ended September 30, 2009.
Conference Call
Conmed will host a conference call today, Thursday, November 12, at 4:30 PM ET. Anyone interested in participating should call 888-846-5003 if calling within the United States or 480-629-9856 if calling internationally. A re-play will be available until November 19, 2009, which can be accessed by dialing 800-406-7325 if calling within the United States or 303-590-3030 if calling internationally. Please use passcode 4179976 to access the replay.
The call will also be accompanied live by webcast over the Internet and accessible at http://viavid.net/dce.aspx?sid=00006C93.
About Conmed
Conmed has provided correctional healthcare services since 1984, beginning in the State of Maryland, and currently serves county and municipal correctional facilities in thirty-six counties in seven states, including Arizona, Kansas, Maryland, Oklahoma, Oregon, Virginia and Washington. Conmed's services have expanded to include mental health, pharmacy and out-of-facility healthcare services.
Forward Looking Statements
This press release may contain, among other things, certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, (i) statements with respect to the Company's plans, objectives, expectations and intentions; and (ii) other statements that are not historical facts including statements which may be identified by words such as "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "projects," "potentially," or similar expressions. These statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company's control) including, without limitation, the Company's ability to increase revenue and to continue to obtain new contracts, contract renewals and extensions.; the ability to obtain bonds; decreases in occupancy levels or disturbances at detention centers; malpractice litigation; the ability to utilize third party administrators for out-of-facility care; compliance with laws and government regulations, including those relating to healthcare; competition; termination of contracts due to lack of government appropriations; material adverse changes in economic and industry conditions in the healthcare market; negative publicity regarding the provision of correctional healthcare services; dependence on key personnel and the ability to hire skilled personnel; increases in healthcare costs; insurance; completion and integration of future acquisitions; public company obligations; and stock price volatility. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission, including Amendment No. 1 to the Company’s Annual Report on Form 10-K/A filed with the SEC for the fiscal year ended December 31, 2008. Investors and security holders are urged to read this document free of charge on the SEC's web site at www.sec.gov. The Company does not undertake to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
CONMED HEALTHCARE MANAGEMENT, INC.CONSOLIDATED BALANCE SHEETS
| | | | | | | |
| | | (unaudited) | | | | |
| ASSETS | | | | | | |
| CURRENT ASSETS | | | | | | |
| Cash and cash equivalents | | $ | 10,119,183 | | | $ | 7,472,140 | |
| Accounts receivable | | | 2,837,599 | | | | 2,375,583 | |
| Prepaid expenses | | | 176,779 | | | | 291,599 | |
| Total current assets | | | 13,133,561 | | | | 10,139,322 | |
| PROPERTY AND EQUIPMENT, NET | | | 650,531 | | | | 529,304 | |
| DEFERRED TAXES | | | 1,022,000 | | | | 645,000 | |
| OTHER ASSETS | | | | | | | | |
| Service contracts acquired, net | | | 817,000 | | | | 2,004,000 | |
| Non-compete agreements, net | | | 532,667 | | | | 821,667 | |
| Goodwill | | | 6,263,705 | | | | 6,254,544 | |
| Deposits | | | 15,683 | | | | 15,408 | |
| Total other assets | | | 7,629,055 | | | | 9,095,619 | |
| | | $ | 22,435,147 | | | $ | 20,409,245 | |
| | | | | | | | | |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | | | |
| CURRENT LIABILITIES | | | | | | | | |
| Accounts payable | | $ | 1,201,145 | | | $ | 1,080,259 | |
| Accrued expenses | | | 3,977,339 | | | | 3,210,749 | |
| Taxes payable | | | 653,240 | | | | 432,380 | |
| Deferred revenue | | | 936,622 | | | | 561,734 | |
| Notes payable, current portion | | | 11,446 | | | | 170,228 | |
| Total current liabilities | | | 6,779,792 | | | | 5,455,350 | |
| NOTES PAYABLE, LONG-TERM | | | -- | | | | 35,000 | |
| DERIVATIVE FINANCIAL INSTRUMENTS | | | 3,720,867 | | | | -- | |
| SHAREHOLDERS’ EQUITY | | | | | | | | |
| Preferred stock, no par value; authorized 5,000,000 shares; issued and outstanding zero shares as of September 30, 2009 and December 31, 2008 | | | -- | | | | -- | |
| Common stock, $0.0001 par value, authorized 40,000,000 shares; issued and outstanding 12,613,322 and 12,457,539 shares as of September 30, 2009 and December 31, 2008, respectively | | | 1,261 | | | | 1,246 | |
| Additional paid-in capital | | | 35,697,560 | | | | 36,875,610 | |
| Retained (deficit) | | | (23,764,333 | ) | | | (21,957,961 | ) |
| Total shareholders' equity | | | 11,934,848 | | | | 14,918,895 | |
| | | $ | 22,435,147 | | | $ | 20,409,245 | |
| | | For the Nine Months Ended September 30, 2009 | | | For the Nine Months Ended September 30, 2008 | | | For the Three Months Ended September 30, 2009 | | | For the Three Months Ended September 30, 2008 | |
| | | | | | | | | | | | | |
| Service contract revenue | | $ | 38,775,309 | | | $ | 28,362,281 | | | $ | 13,643,317 | | | $ | 11,531,168 | |
| | | | | | | | | | | | | | | | | |
| HEALTHCARE EXPENSES: | | | | | | | | | | | | | | | | |
| Salaries, wages and employee benefits | | | 22,138,330 | | | | 14,695,467 | | | | 7,900,235 | | | | 5,975,707 | |
| Medical expenses | | | 7,248,420 | | | | 7,702,791 | | | | 2,485,024 | | | | 3,042,867 | |
| Other operating expenses | | | 1,388,780 | | | | 933,932 | | | | 524,950 | | | | 446,228 | |
| Total healthcare expenses | | | 30,775,530 | | | | 23,332,190 | | | | 10,910,209 | | | | 9,464,802 | |
| | | | | | | | | | | | | | | | | |
| Gross profit | | | 7,999,779 | | | | 5,030,091 | | | | 2,733,108 | | | | 2,066,366 | |
| | | | | | | | | | | | | | | | | |
| Selling and administrative expenses | | | 5,774,101 | | | | 4,574,429 | | | | 2,014,378 | | | | 1,490,008 | |
| Depreciation and amortization | | | 1,627,951 | | | | 1,533,870 | | | | 387,392 | | | | 504,295 | |
| Total operating expenses | | | 7,402,052 | | | | 6,108,299 | | | | 2,401,770 | | | | 1,994,303 | |
| | | | | | | | | | | | | | | | | |
| Operating income (loss) | | | 597,727 | | | | (1,078,208 | ) | | | 331,338 | | | | 72,063 | |
| | | | | | | | | | | | | | | | | |
| OTHER INCOME (EXPENSE) | | | | | | | | | | | | | | | | |
| Interest income | | | 61,127 | | | | 145,085 | | | | 16,547 | | | | 37,934 | |
| Interest (expense) | | | (7,991 | ) | | | (4,721 | ) | | | (819 | ) | | | (1,527 | ) |
| Change in fair value of derivatives | | | (1,688,623 | ) | | | -- | | | | 755,650 | | | | -- | |
| Total other income (expense) | | | (1,635,487 | ) | | | 140,364 | | | | 771,378 | | | | 36,407 | |
| | | | | | | | | | | | | | | | | |
| Income (loss) before income taxes | | | (1,037,760 | ) | | | (937,844 | ) | | | 1,102,716 | | | | 108,470 | |
| Income tax (expense) | | | (402,000 | ) | | | -- | | | | (249,000 | ) | | | -- | |
| Net income (loss) | | $ | (1,439,760 | ) | | $ | (937,844 | ) | | $ | 853,716 | | | $ | 108,470 | |
| | | | | | | | | | | | | | | | | |
| EARNINGS (LOSS) PER COMMON SHARE | | | | | | | | | | | | | | | | |
| Basic | | $ | (0.11 | ) | | $ | (0.08 | ) | | $ | 0.07 | | | $ | 0.01 | |
| Diluted | | $ | (0.11 | ) | | $ | (0.08 | ) | | $ | 0.01 | | | $ | 0.01 | |
| | | | | | | | | | | | | | | | | |
| WEIGHTED-AVERAGE SHARES OUTSTANDING | | | | | | | | | | | | | | | | |
| Basic | | | 12,546,754 | | | | 12,012,681 | | | | 12,606,699 | | | | 12,024,222 | |
| Diluted | | | 12,546,754 | | | | 12,012,681 | | | | 14,183,486 | | | | 13,305,347 | |
CONMED HEALTHCARE MANAGEMENT, INC.CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
| | | For the Nine Months Ended September 30, 2009 | | | For the Nine Months Ended September 30, 2008 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | | | | | | |
| Net (loss) | | $ | (1,439,760 | ) | | $ | (937,844 | ) |
| Adjustments to reconcile net income to net cash provided by operating activities | | | | | | | | |
| Depreciation | | | 151,951 | | | | 72,870 | |
| Amortization | | | 1,476,000 | | | | 1,461,000 | |
| Stock-based compensation | | | 475,597 | | | | 423,221 | |
| Loss on disposal of property | | | -- | | | | 2,257 | |
| Deferred income taxes | | | (377,000 | ) | | | (300,000 | ) |
| Change in fair value of derivatives | | | 1,688,623 | | | | -- | |
| Changes in working capital components | | | | | | | | |
| (Increase) in accounts receivable | | | (462,016 | ) | | | (1,086,746 | ) |
| Decrease (increase) in prepaid expenses | | | 114,820 | | | | (277,580 | ) |
| Decrease (increase) in deposits | | | (275 | ) | | | 19,999 | |
| Increase in accounts payable | | | 120,886 | | | | 49,724 | |
| Increase in accrued expenses | | | 766,590 | | | | 2,254,553 | |
| Increase in income taxes payable | | | 220,860 | | | | 203,260 | |
| Increase (decrease) in deferred revenue | | | 374,888 | | | | (133,923 | ) |
| Net cash provided by operating activities | | | 3,111,164 | | | | 1,750,791 | |
| | | | | | | | | |
| CASH FLOWS FROM INVESTING ACTIVITIES | | | | | | | | |
| Purchase of property and equipment | | | (273,178 | ) | | | (357,918 | ) |
| Asset Purchase from EMDC, P.C. | | | -- | | | | (245,853 | ) |
| Stock Purchase of CMHS, LLC | | | (9,161 | ) | | | -- | |
| Net cash used in investing activities | | | (282,339 | ) | | | (603,771 | ) |
| | | | | | | | | |
| CASH FLOWS FROM FINANCING ACTIVITIES | | | | | | | | |
| Payments on line of credit | | | (100,000 | ) | | | -- | |
| Payments on loans | | | (93,782 | ) | | | (53,964 | ) |
| Proceeds from exercise of warrants | | | 12,000 | | | | -- | |
| Net cash used in financing activities | | | (181,782 | ) | | | (53,964 | ) |
| | | | | | | | | |
| Net increase in cash and cash equivalents | | | 2,647,043 | | | | 1,093,056 | |
| | | | | | | | | |
| CASH AND CASH EQUIVALENTS | | | | | | | | |
| Beginning | | | 7,472,140 | | | | 7,136,720 | |
| Ending | | $ | 10,119,183 | | | $ | 8,229,776 | |
CONMED HEALTHCARE MANAGEMENT, INC.
RECONCILIATION OF PROFORMA GAAP NET LOSS FROM CONTINUING OPERATIONS TO EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION AND AMORTIZATION (EBITDA) AND ADJUSTED EBITDA
| | | For the Nine Months Ended September 30, 2009 | | | For the Nine Months Ended September 30, 2008 | | | For the Three Months Ended September 30, 2009 | | | For the Three Months Ended September 30, 2008 | |
| EBITDA RECONCILIATION | | | | | | | | | | | | |
| Net income (loss) | | $ | (1,439,760 | ) | | $ | (937,844 | ) | | $ | 853,716 | | | $ | 108,470 | |
| Income tax expense | | | 402,000 | | | | -- | | | | 249,000 | | | | -- | |
| Interest (income) | | | (61,127 | ) | | | (145,085 | ) | | | (16,547 | ) | | | (37,934 | ) |
| Interest expense | | | 7,991 | | | | 4,721 | | | | 819 | | | | 1,527 | |
| Depreciation and Amortization | | | 1,627,951 | | | | 1,533,870 | | | | 387,392 | | | | 504,295 | |
| EBITDA | | | 537,055 | | | | 455,662 | | | | 1,474,380 | | | | 576,358 | |
| Stock-based compensation | | | 475,597 | | | | 423,221 | | | | 151,328 | | | | 159,974 | |
| Change in fair value of warrants | | | 1,688,623 | | | | -- | | | | (755,650 | ) | | | -- | |
| Gain or Loss on Sale of Assets | | | -- | | | | 2,257 | | | | -- | | | | -- | |
| Adjusted EBITDA | | $ | 2,701,275 | | | $ | 881,140 | | | $ | 870,058 | | | $ | 736,332 | |
Contact:
Conmed Healthcare Management, Inc.
Thomas W. Fry, 410-567-5529
Chief Financial Officer
tfry@conmed-inc.com
or
Hayden IR
Peter Seltzberg, 646-415-8972
peter@haydenir.com
